Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors

Molecular Pharmacology

Volumn 60, Issue 4, 2001, Pages 776-784

  Fischer, David J ^a,c   Nusser, Nora ^a   Virag, Tamas ^a   Yokoyama, Kazuaki ^a   Wang, De An ^a   Baker, Daniel L ^a   Bautista, Debra ^b   Parrill, Abby L ^b   Tigyi, Gabor ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b University of Memphis   (United States)

^c EMD SERONO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; DIOCTYLGLYCEROLPYROPHOSPHATE; DIOCTYLPHOSPHATIDIC ACID; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR RECEPTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDIC ACID RECEPTOR 3; LYSOPHOSPHATIDIC ACID RECEPTOR 3 BLOCKING AGENT; LYSOPHOSPHATIDIC ACID RECEPTOR BLOCKING AGENT; PHOSPHATIDIC ACID; RECEPTOR SUBTYPE; SEROTONIN; SPHINGOSINE 1 PHOSPHATE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; NONHUMAN; OOCYTE; OVARY CANCER; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; XENOPUS LAEVIS;

3T3 CELLS; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING, COMPETITIVE; CALCIUM; CELL DIVISION; CELL LINE; DIPHOSPHATES; GLYCEROL; MICE; OOCYTES; PC12 CELLS; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RECEPTORS, LYSOPHOSPHOLIPID; SEROTONIN; THROMBIN; XENOPUS LAEVIS;

EID: 0034812654     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Transduction of intracellular calcium, signals through G protein-mediated activation of phospholipase C by recombinant sphingosine 1-phosphate receptors
2. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization
3. Proinflammatory macrophage-activating properties of the novel phospholipid diacylglycerol pyrophosphate
4. Molecular cloning and characterization of a novel human G-protein- coupled receptor. EDG7, for lysophosphatidic acid
5. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptore
6. Differential inhibition of lysophosphatidate signaling by volatile anesthetics
7. Lysophosphatidic acid receptors
8. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
9. A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid
10. Lysophospholipid growth factors
11. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue
12. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation
13. Molecular cloning of a high affinity receptor for the growth factor-like phospholipid mediator lysophosphatidic acid
14. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
15. Characterization of a receptor subtype-selective lysophosphatidic acid mimetic
16. Lysophosphatidic acid induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent
17. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8
18. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
19. 2+ mobilization in human A431 cells: Structure-activity analysis
20. Two novel Xenopus homologs of mammalian LPA1/EDG-2 function as lysophosphatidic acid receptors in Xenopus oocytes and mammalian cells
21. N-Palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors
22. Identification of diacylglycerol pyrophosphate as a novel metabolic product of phosphatidic acid during G-protein activation in plants
23. Identification of edg1 receptor residues that recognize sphingosine 1-phosphate
24. Diacyl-(8:0)-glyceropyrophosphate, a new Edg-receptor antagonist, blocks LPA-induced shape change in human platelets
25. A novel lysophosphatidic acid analog, LXR-1035, inhibits leukocyte-endothelium interaction via inhibition of cell adhesion molecules
26. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
27. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: Comparison with platelet activating factor
28. Physiological responses to lysophosphatidic acid and related glycerophospholipids
29. Pharmacological characterization of phospholipid growth factor receptors
30. 2+ signaling and Rho
31. Phospholipid growth factors: Identification and mechanism of action
32. Local anesthetics inhibit receptors coupled to phosphoinositide signaling in Xenopus oocytes
33. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin
34. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins
35. Diacylglycerol pyrophosphate, a novel phospholipid compound
36. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients